Commonwealth Equity Services, LLC Amgen Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 387,356 shares of AMGN stock, worth $111 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

387,356

Previous 386,870 0.13%

Holding current value

$111 Million

Previous $121 Million 3.25%

% of portfolio

0.19%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $150,358 - $163,966	486 Added 0.13%	387,356 $125 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $1.88 Million - $2.28 Million	-7,150 Reduced 1.81%	386,870 $121 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $2.94 Million - $3.55 Million	10,942 Added 2.86%	394,020 $112 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $1.87 Million - $2.1 Million	7,296 Added 1.94%	383,078 $110 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $2.47 Million - $3.07 Million	11,309 Added 3.1%	375,782 $101 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $3.23 Million - $3.82 Million	-15,067 Reduced 3.97%	364,473 $80.9 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $8.4 Million - $10.2 Million	37,191 Added 10.86%	379,540 $91.8 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $1.12 Million - $1.42 Million	4,888 Added 1.45%	342,349 $89.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $229,847 - $259,225	1,024 Added 0.3%	337,461 $76.1 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $226,095 - $251,605	-980 Reduced 0.29%	336,437 $81.9 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $1.78 Million - $1.97 Million	8,104 Added 2.46%	337,417 $81.6 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $2.24 Million - $2.57 Million	11,276 Added 3.55%	329,313 $74.1 Million
Q3 2021 Oct 29, 2021	BUY	$212.27 - $248.7 $1.1 Million - $1.28 Million	5,163 Added 1.65%	318,037 $67.6 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $2.73 Million - $3.02 Million	11,672 Added 3.88%	312,874 $76.3 Million
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $70,789 - $82,493	-319 Reduced 0.11%	301,202 $74.9 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $1.95 Million - $2.32 Million	-9,012 Reduced 2.9%	301,521 $69.3 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $1.22 Million - $1.36 Million	-5,195 Reduced 1.65%	310,533 $78.9 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $3.19 Million - $3.91 Million	16,110 Added 5.38%	315,728 $74.5 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $2.29 Million - $3.04 Million	12,587 Added 4.39%	299,618 $60.7 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $2.08 Million - $2.67 Million	10,996 Added 3.98%	287,031 $69.2 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $874,032 - $1.05 Million	5,020 Added 1.85%	276,035 $53.4 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $1.53 Million - $1.8 Million	9,207 Added 3.52%	271,015 $49.9 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $1.22 Million - $1.37 Million	6,731 Added 2.64%	261,808 $49.7 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $1.38 Million - $1.61 Million	7,721 Added 3.12%	255,077 $49.7 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $276,637 - $311,872	-1,493 Reduced 0.6%	247,356 $51.3 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $521,895 - $586,200	3,143 Added 1.28%	248,849 $45.9 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $428,319 - $500,544	2,528 Added 1.04%	245,706 $41.9 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $41 Million - $45.9 Million	243,178	243,178 $42.3 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Amgen Inc Transaction History